The US Food and Drug Administration (FDA) approved on Friday a new drug from Bristol-Myers Squib to treat patients with metastatic or late-stage melanoma, the most deadly type of skin cancer.
via myfoxphoenix.com
Here is good news for late-stage skin cancer sufferers.
No comments:
Post a Comment